Literature DB >> 10633271

Effect of intermittent administration of human parathyroid hormone (1-34) on the mandibular condyle of ovariectomized rats.

M Nakajima1, S Ejiri, M Tanaka, E Toyooka, S Kohno, H Ozawa.   

Abstract

Intermittent administration of human parathyroid hormone (1-34) (PTH) increases bone mass in lumbar vertebrae and long bones of osteoporotic experimental animals. However, whether PTH has the same effect on jaw bones remains unclear. This study determined the effect of intermittent administration of PTH on rat mandibular condyle affected by estrogen deficiency. Fifty 6-month-old rats were either sham operated or ovariectomized, then divided into five groups depending on surgical procedure and hormone administration: sham + vehicle (SV), OVX + vehicle (OV), OVX + PTH 6 micrograms/kg once per week (OP6-1), OVX + PTH 60 micrograms/kg once per week (OP60-1), and OVX + PTH 20 micrograms/kg three times per week (OP20-3). PTH or vehicle was injected intermittently for 6 months in 5 rats of each group either immediately after surgery in a preventive administration experiment, or injected starting 6 months after surgery in a therapeutic administration experiment. The mandibles were excised, and bone morphometry was performed using confocal laser scanning microscopy and soft X-ray images. In both experiments, the bone volume of the OV groups was significantly lower than that of the SV group (P < 0.01); also, depending on dose and frequency, the bone volume of the OP group was higher than that of the OV group, particularly in the OP20-3 group. The value of mineralized surface of the OP groups was significantly higher than that of the OV group (P < 0.01), whereas the value of eroded surface of the OP groups was not significantly higher than that of the OV group. This study indicates that preventive and therapeutic intermittent administration of PTH in ovariectomized rats increase the bone formation in rat mandibular condyle without accelerating bone resorptive activity. This anabolic effect was best induced by the injection mode of 20 micrograms/kg three times per week.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10633271     DOI: 10.1007/s007740050003

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  4 in total

Review 1.  Parathyroid hormone applications in the craniofacial skeleton.

Authors:  H L Chan; L K McCauley
Journal:  J Dent Res       Date:  2012-10-15       Impact factor: 6.116

Review 2.  Estrogen deficiency and its effect on the jaw bones.

Authors:  Sadakazu Ejiri; Mikako Tanaka; Naoko Watanabe; Rezwana Binte Anwar; Emi Yamashita; Kazuho Yamada; Mika Ikegame
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

3.  Intermittent parathyroid hormone treatment affects the bone structural parameters and mechanical strength of the femoral neck after ovariectomy-induced osteoporosis in rats.

Authors:  Shun-Ping Wang; Ying-Ju Chen; Cheng-En Hsu; Yung-Cheng Chiu; Ming-Tzu Tsai; Jui-Ting Hsu
Journal:  Biomed Eng Online       Date:  2022-01-29       Impact factor: 2.819

4.  Intermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats.

Authors:  Ying-Ju Chen; Shun-Ping Wang; Fu-Chou Cheng; Pei-Yu Hsu; Yu-Fen Li; Jay Wu; Heng-Li Huang; Ming-Tzu Tsai; Jui-Ting Hsu
Journal:  BMC Musculoskelet Disord       Date:  2017-04-24       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.